logo
Plus   Neg
Share
Email

Roche Q1 Sales Up 9%; Raises FY Outlook

Swiss drug major Roche (RHHBY) reported that its group sales for the first-quarter rose 9 percent to 14.83 billion Swiss francs from last year's 13.58 billion francs, while it was up 8 percent at constant exchange rates. The company raised outlook for 2019.

Sales in the Pharmaceuticals Division increased 10% to 11.9 billion francs. The growth drivers were the multiple sclerosis medicine Ocrevus and cancer medicines Perjeta and Tecentriq as well as the new haemophilia medicine Hemlibra. The strong uptake of newly introduced medicines was partially offset by lower sales of Herceptin and of MabThera/Rituxan, the company said.

In the US, sales increased 14%, led by Ocrevus, Hemlibra, Perjeta and Tecentriq. Ocrevus sales were driven by both new and continuing patient demand.

For 2019, Roche now expects sales to grow in the mid-single digit range, at constant exchange rates. Core earnings per share are targeted to grow broadly in line with sales, at constant exchange rates. It expects to further increase its dividend in Swiss francs.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Trade Commission (FTC) is in the process of sending out refund checks to consumers who were allegedly misled by Office Depot, Inc. and its software provider Support.com, Inc., into buying computer repair products and services. Out of $34 million, being the total amount of checks, Office Depot paid $25 million and Support.com paid $10 million as part of 2019 settlement. Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project...
Follow RTT
>